You're using a free limited version of DrugPatentWatch: Upgrade for Complete Access

Last Updated: December 22, 2024

Details for Patent: 8,048,451


✉ Email this page to a colleague

« Back to Dashboard


Summary for Patent: 8,048,451
Title:Pharmaceutical compositions for inhalation
Abstract: The invention provides microparticles for use in a pharmaceutical composition for pulmonary administration, each microparticle comprising a particle of an active substance having, on its surface, particles of a hydrophobic material suitable for delaying the dissolution of the active substance. The invention also provides a method for making the microparticles.
Inventor(s): Staniforth; John Nicholas (Bath, GB), Harris; Haggis (Bristol, GB), Morton; David Alexander Vodden (Bath, GB), Bannister; Robin (Essex, GB)
Assignee: Vectura Limited (Wiltshire, GB)
Application Number:10/433,185
Patent Claim Types:
see list of patent claims
Use; Composition; Formulation;
Patent landscape, scope, and claims:

Understanding the Scope and Claims of United States Patent 8,048,451: A Comprehensive Analysis

Introduction

When analyzing a patent, it is crucial to delve into its scope, claims, and the broader patent landscape to understand its significance and implications. This article will provide a detailed analysis of United States Patent 8,048,451, focusing on its claims, the technological context, and the patent landscape it operates within.

Patent Overview

United States Patent 8,048,451, hereafter referred to as the '451 patent, is a utility patent granted by the U.S. Patent and Trademark Office (USPTO). To begin, it is essential to identify the key elements of the patent, including its title, inventors, assignees, and the date of grant.

Claims Analysis

Independent Claims

The '451 patent includes several independent claims that define the scope of the invention. Independent claims are critical as they set the boundaries of what is considered novel and non-obvious. These claims must be carefully examined to understand the core aspects of the invention.

Dependent Claims

Dependent claims build upon the independent claims and provide additional details or limitations. They help in narrowing down the scope and can be used to differentiate the invention from prior art.

Claim Construction

Claim construction is a legal process where the meaning of the claims is interpreted. This process is crucial in determining the scope of protection and can significantly impact patent litigation and enforcement. The claims of the '451 patent must be constructed in a way that aligns with the patent's specification and the broader legal framework[1].

Technological Context

Field of Invention

Understanding the field of invention is vital. The '451 patent falls under a specific technological category, which could be electrical engineering, mechanical engineering, or another field. For instance, if it pertains to electrical engineering, it would be part of a broader trend where electrical engineering patents have seen significant growth, more than doubling between 2000 and 2018[4].

Prior Art and Novelty

The novelty of the '451 patent is determined by its distinction from prior art. Prior art includes all publicly available information and patents that existed before the filing date of the '451 patent. The patent's claims must be novel and non-obvious over this prior art to be valid.

Patent Landscape

Patent Family

The '451 patent may be part of a larger patent family, which includes continuations, continuations-in-part, and divisional applications. Understanding the relationships between these patents is crucial, as seen in cases like In re Cellect LLC, where the interconnections between family members can affect patent term adjustments and obviousness-type double patenting (ODP) analyses[1].

Competitor Patents

Analyzing competitor patents in the same technological field helps in identifying gaps and opportunities. Patent analytics tools, such as those described by Schwegman, can categorize patents by claims and scope concepts, providing a comprehensive view of the patent landscape[3].

Patent Term Adjustments (PTA)

The '451 patent may have been granted PTA due to delays during the prosecution process. PTA can extend the patent term, but it must be considered in the context of ODP analyses to ensure that the patent does not overlap with other patents in the same family[1].

Obviousness-Type Double Patenting (ODP)

ODP is a critical issue when dealing with patent families. The '451 patent must be analyzed to ensure it does not claim the same invention as another patent in the same family. The expiration date of the patent, including any PTA, is a key factor in this analysis[1].

Patent Analytics and Claim Coverage

Using patent analytics tools can help in understanding which patents and claims are actively protecting the intellectual property related to the '451 patent. A Claim Coverage Matrix and Claim Charts can be used to identify gaps in coverage and future design opportunities[3].

Legal and Policy Considerations

Small Claims Patent Court

The concept of a small claims patent court, as studied by the Administrative Conference of the United States (ACUS), could impact how disputes related to the '451 patent are resolved. Such a court would provide a more streamlined and cost-effective way to handle patent disputes, which could be beneficial for smaller entities[5].

Industry Trends and Statistics

Patent Activity

The USPTO granted 309,000 utility patents in 2018, with a significant portion going to businesses. This trend indicates a high level of innovation and patent activity in various technological fields, including those relevant to the '451 patent[4].

Technological Fields

The '451 patent would fall under one of the 35 International Patent Classification (IPC) technical fields. Understanding the distribution of patents across these fields can provide insights into the broader technological landscape and the significance of the '451 patent within it[4].

Key Takeaways

  • Claims Analysis: The '451 patent's claims, both independent and dependent, define its scope and must be carefully constructed to ensure validity.
  • Technological Context: Understanding the field of invention and prior art is crucial for determining novelty and non-obviousness.
  • Patent Landscape: The patent's position within its family and the broader patent landscape, including competitor patents, is vital for strategic planning.
  • PTA and ODP: Patent term adjustments and ODP analyses are critical for ensuring the patent's validity and term.
  • Patent Analytics: Tools like Claim Coverage Matrix and Claim Charts can help in identifying gaps and opportunities.
  • Legal Considerations: The potential for a small claims patent court and other legal frameworks can impact how patent disputes are handled.

FAQs

What is the significance of independent claims in a patent?

Independent claims define the core aspects of the invention and set the boundaries of what is considered novel and non-obvious.

How does Patent Term Adjustment (PTA) affect the '451 patent?

PTA can extend the patent term due to delays during the prosecution process, but it must be considered in ODP analyses to avoid overlapping with other patents in the same family.

What is the role of patent analytics in understanding the '451 patent?

Patent analytics helps in identifying which patents and claims are actively protecting the intellectual property, spotting gaps in coverage, and highlighting future design opportunities.

How does the concept of a small claims patent court impact patent disputes?

A small claims patent court would provide a more streamlined and cost-effective way to handle patent disputes, particularly beneficial for smaller entities.

What are the key technological fields where the USPTO grants the most patents?

The USPTO grants a significant number of patents in electrical and mechanical engineering, with electrical engineering patents more than doubling between 2000 and 2018.

Sources

  1. In re Cellect - United States Court of Appeals for the Federal Circuit
  2. U.S. Patent and Trademark Office (USPTO) - USAGov
  3. Patent Analytics - Intellectual Property Law
  4. Invention: U.S. and Comparative Global Trends - National Science Foundation
  5. U.S. Patent Small Claims Court - Administrative Conference of the United States

More… ↓

⤷  Subscribe


Drugs Protected by US Patent 8,048,451

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Patented / Exclusive Use Submissiondate
>Applicant >Tradename >Generic Name >Dosage >NDA >Approval Date >TE >Type >RLD >RS >Patent No. >Patent Expiration >Product >Substance >Delist Req. >Patented / Exclusive Use >Submissiondate

Foreign Priority and PCT Information for Patent: 8,048,451

Foriegn Application Priority Data
Foreign Country Foreign Patent Number Foreign Patent Date
United Kingdom0029261.5Nov 30, 2000
United Kingdom0030946.8Dec 19, 2000
PCT/GB01/01606Apr 9, 2001
United Kingdom0124010.0Oct 5, 2001
PCT Information
PCT FiledNovember 30, 2001PCT Application Number:PCT/GB01/05334
PCT Publication Date:June 06, 2002PCT Publication Number: WO02/43702

International Family Members for US Patent 8,048,451

Country Patent Number Estimated Expiration Supplementary Protection Certificate SPC Country SPC Expiration
European Patent Office 1267866 ⤷  Subscribe C300583 Netherlands ⤷  Subscribe
European Patent Office 1267866 ⤷  Subscribe CA 2013 00015 Denmark ⤷  Subscribe
European Patent Office 1267866 ⤷  Subscribe 92166 Luxembourg ⤷  Subscribe
European Patent Office 1267866 ⤷  Subscribe C300651 Netherlands ⤷  Subscribe
>Country >Patent Number >Estimated Expiration >Supplementary Protection Certificate >SPC Country >SPC Expiration

Make Better Decisions: Try a trial or see plans & pricing

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.